MIR3131

Across TCGA pan-cancer cohorts, MIR3131 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of MIR3131’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where MIR3131 RNA is repressed in tumor relative to normal tissue. In most cancer types MIR3131 is over-expressed in tumor, although a few such as LUAD and LUSC show the opposite, repressed pattern.

LUAD, LIHC, and LUSC are the cancer types where MIR3131 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR3131 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	Female	All	−0.876	<.001	7	view →
LIHC	All	All	+0.672	<.001	7	view →
LUSC	All	II,III,IV	−1.112	<.001	6	view →
KICH	All	II,III,IV	−0.898	.004	4	view →
STAD	All	All	+1.100	.015	3	view →
PAAD	All	All	+2.917	.027	2	view →
KIRP	Female	II,III,IV	−1.081	.033	2	view →
KIRC	Female	III,IV	+0.859	.027	2	view →
READ	Female	All	+1.158	.021	1	view →
CHOL	All	All	+1.090	.023	1	view →
THCA	Female	All	−0.111	.048	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

MIR3131–LUAD

Open the LUAD breakdown →